Dr. Agarwal’s Health Care Limited provides a comprehensive range of eye care services, including cataract and refractive surgeries, consultations, diagnostics, and non-surgical treatments. It also offers optical products, contact lenses, and eye care pharmaceuticals. According to the CRISIL MI&A Report, the company held a 25% market share in India’s eye care service chain market in FY 2024. As of September 30, 2024, its network included 209 facilities, ensuring accessible and quality eye care services. Beyond India, the company expanded internationally in 2012 and, as of September 30, 2024, operates 16 facilities across nine countries in Africa.
Price Band₹382 - ₹402 |
Dates29 Jan - 31 Jan |
GMP₹0 (0.00%) |
Subscriptions1.55 times |
Issue Size₹3,027.26 Crs |
1. Repayment of certain borrowings.
2. General corporate purposes and unidentified inorganic acquisition.
Price Band₹382 - ₹402 |
Listing AtNSE & BSE |
IPO Issue Type100% Book Built Offer |
Fresh Issue₹300.00 Cr (0.75 Cr Shares) |
Offer For Sale₹2,727.26 Cr (6.51 Cr Shares) |
Total Issue₹3,027.26 Cr (7.26 Cr Shares) |
Face Value₹1 per equity share |
Investor Category | Lot | Shares | Amount | |
---|---|---|---|---|
Retail |
Minimum
1
35
14,070
Maximum
14
490
1,96,980
|
|||
Small HNI |
Minimum
15
525
2,11,050
Maximum
71
2,485
9,98,970
|
|||
Big HNI |
Minimum
72
2,520
10,13,040
|
Updated as on 31-Jan-2025 19:00:00
Investor Category | Subscription (times) | Shares Offered | Shared Bid |
---|---|---|---|
QIB | 4.64 | 1,45,19,200 | 6,73,61,280 |
NII | 0.40 | 1,08,89,400 | 43,07,310 |
bNII (bids above ₹10L) | 0.31 | 72,59,600 | 22,85,955 |
sNII (bids between ₹2L to ₹10L) | 0.56 | 36,29,800 | 20,21,355 |
Retail | 0.41 | 2,54,08,599 | 1,05,40,285 |
Employee | 0.27 | 15,79,399 | 4,25,565 |
Others | 0.52 | 11,29,574 | 5,83,940 |
Total | 1.55 | 5,35,26,172 | 8,32,18,380 |
Subscription data excludes the Anchor Investor portion.
The estimated Grey Market Premium of Dr.Agarwal IPO is ₹0 per share (0.00%)
Particulars | Allocation |
---|---|
QIBs | Not more than 50% of Net Offer |
Big HNIs (NII) | Not less than 10% of Net Offer |
Small HNIs (NII) | Not less than 5% of Net Offer |
Retail | Not less than 35% of Net Offer |
Particulars | Sep-24 | Mar-24 | Mar-23 | Mar-22 |
---|---|---|---|---|
Revenue from Operations | 837.94 | 1,376.45 | 1,031.49 | 713.78 |
Profit after Tax | 39.56 | 95.05 | 103.23 | 43.16 |
Net Worth | 1,502.67 | 1,337.68 | 627.83 | 212.34 |
Total Borrowing | 373.68 | 387.79 | 356.18 | 290.18 |
Total Assets | 3,393.41 | 2,752.82 | 1,825.17 | 1,026.13 |
NAV per share (in ₹) | 52.72 | 50.53 | 26.73 | 10.32 |
EPS - Basic (in ₹) | 1.00 | 3.14 | 4.01 | 1.83 |
The financial information presented is on a consolidated basis.
KPI | KPI |
---|---|
ROCE (%) | 14.61% |
ROE (%) | 9.33% |
Net Debt to Equity | 2.07 |
EBITDA (%) | 29.54% |
PAT (%) | 6.91% |
Price to earning (PE) | 128.03 |
Mkt Cap (in Crs.) | 12,698 |
Price to Book (PB) | 7.96 |
Particulars | Co. | Apollo Hospitals | Max Healthcare | Fortis Healthcare | Global Health | Narayana Hrudayalaya | Krishna Institute of Medical Sciences | Krishna Institute of Medical Sciences | Rainbow Children's Medicare |
---|---|---|---|---|---|---|---|---|---|
Revenue from operations | 1,332.15 | 19,059.20 | 6,849.00 | 6,892.92 | 3,275.11 | 5,018.25 | 2,498.14 | 3,698.90 | 1,296.90 |
Profit after Tax | 95.05 | 935.00 | 1,278.00 | 645.22 | 478.06 | 789.62 | 336.01 | 211.56 | 218.29 |
EPS (Basic) | 3.14 | 62.50 | 10.89 | 7.93 | 17.80 | 38.86 | 7.75 | 3.60 | 21.38 |
NAV per share | 50.53 | 481.93 | 86.54 | 101.48 | 108.17 | 141.98 | 228.47 | 71.62 | 124.03 |
Price to Earning | 128.03 | 107.11 | 95.88 | 82.11 | 57.49 | 33.14 | 79.79 | 136.07 | 67.90 |
EBITDA Margin | 29.54% | 13.03% | 27.84% | 18.84% | 26.08% | 24.10% | 26.02% | 16.19% | 34.93% |
PAT Margin (%) | 6.91% | 4.88% | 18.66% | 9.31% | 14.27% | 15.50% | 13.38% | 5.68% | 16.36% |
Net Debt equity ratio | 2.07 | 1.76 | 0.10 | 0.43 | NA | 0.99 | 2.00 | 2.11 | 1.62 |
Particulars | Co. |
---|---|
Revenue from operations | 1,332.15 |
Profit after Tax | 95.05 |
EPS (Basic) | 3.14 |
NAV per share | 50.53 |
Price to Earning | 128.03 |
EBITDA Margin | 29.54% |
PAT Margin (%) | 6.91% |
Net Debt equity ratio | 2.07 |
Apollo Hospitals | Max Healthcare | Fortis Healthcare | Global Health | Narayana Hrudayalaya | Krishna Institute of Medical Sciences | Krishna Institute of Medical Sciences | Rainbow Children's Medicare |
---|---|---|---|---|---|---|---|
19,059.20 | 6,849.00 | 6,892.92 | 3,275.11 | 5,018.25 | 2,498.14 | 3,698.90 | 1,296.90 |
935.00 | 1,278.00 | 645.22 | 478.06 | 789.62 | 336.01 | 211.56 | 218.29 |
62.50 | 10.89 | 7.93 | 17.80 | 38.86 | 7.75 | 3.60 | 21.38 |
481.93 | 86.54 | 101.48 | 108.17 | 141.98 | 228.47 | 71.62 | 124.03 |
107.11 | 95.88 | 82.11 | 57.49 | 33.14 | 79.79 | 136.07 | 67.90 |
13.03% | 27.84% | 18.84% | 26.08% | 24.10% | 26.02% | 16.19% | 34.93% |
4.88% | 18.66% | 9.31% | 14.27% | 15.50% | 13.38% | 5.68% | 16.36% |
1.76 | 0.10 | 0.43 | NA | 0.99 | 2.00 | 2.11 | 1.62 |
Name | Shareholding |
---|---|
Dr. Anosh Agarwal | 7.16% |
Dr. Athiya Agarwal | 6.99% |
Dr. Amar Agarwal | 5.78% |
Dr. Adil Agarwal | 5.71% |
Other Promoters | 11.52% |
Name | Designation |
---|---|
Dr. Amar Agarwal | Chairperson |
Yashwanth Venkat | Chief Financial Officer |
Dr. Adil Agarwal | Chief Executive Officer |
DR. AGARWAL’S HEALTH CARE LIMITED
1st Floor, Buhari Towers, No.4, Moores Road, Off Greams Road, Near Asan Memorial School, Chennai 600 006, Tamil Nadu, India
Email: secretarial@dragarwal.com
Telephone: +91 44 4378 7777
WEBSITE :www.dragarwals.co.in
Find answers to common questions that come in your mind related to IPO.
Dr.Agarwal IPO is a Mainboard IPO having an issue size of Rs. ₹3,027.26 Crs. Dr.Agarwal IPO is priced at ₹382 - ₹402 per share. The issue opens on 29 Jan 25 and closes on 31 Jan 25.
Dr.Agarwal IPO opens on 29 Jan 25 and closes on 31 Jan 25.
The estimated Grey Market Premium of Dr.Agarwal IPO is ₹0 per share (0.00%).
The minimum lot size of Dr.Agarwal IPO is 35 shares & the minimum application amount is Rs. 14070.
The allotment date of Dr.Agarwal IPO is 03 Feb 25.
The listing date of Dr.Agarwal IPO is 05 Feb 25.
Dr.Agarwal IPO is subscribed 1.55 times.
Dr.Agarwal IPO is priced at ₹382 - ₹402 per share.
Click the allotment link on Dr.Agarwal IPO page of IPO360.